MoneyWorks4Me

Lupin informs about grant of stock options

17 Dec 2022 Evaluate

Lupin has informed that the Company granted stock options aggregating 467312 on December 12, 2022 to the employees of the Company and its subsidiaries, at the exercise price of Rs 2.00 each, as approved by the Nomination and Remuneration Committee of the Company on December 17, 2022, details of which are enclosed. One stock option entitles the grantee to subscribe to one equity share of the Company of Rs 2.00 each, after vesting. The vesting schedule of stock options will be 25%:25%:25%:25% over four years upon completion of one year from the date of grant, which is December 12, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..